Security key
87164U508
Theriva Biologics, Inc. - Common stock (TOVX)
CUSIP: 87164U508
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common stock
- Shares outstanding
- 9,600,143
- Total 13F shares
- 34,470
- Share change
- -456,960
- Total reported value
- $60,323
- Price per share
- $1.75
- Number of holders
- 9
- Value change
- -$627,703
- Number of buys
- 3
- Number of sells
- 9
Report period
Q4 2024
Institutions
9
Top holders
10
TOVX full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Theriva Biologics, Inc. SEC filings
Theriva Biologics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164U508
Recent filing periods:
Top shareholders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
146,136
|
$206,052 | $0 | 31 Dec 2024 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
1.5%
|
141,958
|
$195,902 | — | 30 Sep 2024 | |
| Anson Funds Management LP |
13F
|
Company |
1.4%
|
139,046
|
$191,883 | — | 30 Sep 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1%
|
100,000
|
$138,000 | — | 30 Sep 2024 | |
| MSD Partners, L.P. |
13F
|
Company |
0.28%
|
27,316
|
$37,696 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
20,200
|
$27,876 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
17,851
|
$24,634 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
13,566
|
$18,721 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.12%
|
11,806
|
$16,000 | — | 30 Sep 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.11%
|
10,120
|
$13,966 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.08%
|
7,568
|
$10,444 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,294
|
$1,785 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
661
|
$912 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
495
|
$683 | — | 30 Sep 2024 | |
| Iron Horse Wealth Management, LLC |
13F
|
Company |
0%
|
14
|
$19 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
9
|
$12 | — | 30 Sep 2024 | |
| Planning Capital Management Corp |
13F
|
Company |
0%
|
4
|
$6 | — | 30 Sep 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
—
mixed-class rows
|
307
mixed-class rows
|
$58 | — | 30 Sep 2024 | |
| Francis Tufaro |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
100,000
|
— | — | 15 Dec 2022 |
Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) as of Q4 2024
As of 31 Dec 2024,
Theriva Biologics, Inc. - Common stock (TOVX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,470 shares.
The largest 10 holders included
UBS Group AG, CITIGROUP INC, BlackRock, Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, Iron Horse Wealth Management, LLC, IFP Advisors, Inc, SBI Securities Co., Ltd., and DANSKE BANK A/S.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
16
Q4 2024 holders
9
Holder diff
-7
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.